{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:41:51Z","timestamp":1774640511746,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020442","name":"Beijing Municipal Human Resources and Social Security Bureau","doi-asserted-by":"publisher","award":["2021-ZZ-004"],"award-info":[{"award-number":["2021-ZZ-004"]}],"id":[{"id":"10.13039\/501100020442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11263-y","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:17:47Z","timestamp":1763630267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RETRACTED ARTICLE: Anti-tumor effects of GPC3 CAR-iNKT cells in murine models of hepatocellular carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Zixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"25","key":"11263_CR1","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.3748\/wjg.v25.i25.3136","volume":"25","author":"D Neureiter","year":"2019","unstructured":"Neureiter D et al (2019) Hepatocellular carcinoma: therapeutic advances in signaling, epigenetic and immune targets. World J Gastroenterol 25(25):3136\u20133150","journal-title":"World J Gastroenterol"},{"issue":"5","key":"11263_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5306\/wjco.v12.i5.290","volume":"12","author":"K Damiris","year":"2021","unstructured":"Damiris K, Abbad H, Pyrsopoulos N (2021) Cellular based treatment modalities for unresectable hepatocellular carcinoma. World J Clin Oncol 12(5):290\u2013308","journal-title":"World J Clin Oncol"},{"key":"11263_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030447","author":"R Park","year":"2020","unstructured":"Park R et al (2020) Immuno-oncotherapeutic approaches in advanced hepatocellular carcinoma. Vaccines. https:\/\/doi.org\/10.3390\/vaccines8030447","journal-title":"Vaccines"},{"issue":"11","key":"11263_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5500\/wjt.v12.i11.331","volume":"12","author":"K Ouranos","year":"2022","unstructured":"Ouranos K et al (2022) Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World J Transplant 12(11):331\u2013346","journal-title":"World J Transplant"},{"issue":"4","key":"11263_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3748\/wjg.v24.i4.494","volume":"24","author":"YC Li","year":"2018","unstructured":"Li YC et al (2018) Low glucose metabolism in hepatocellular carcinoma with GPC3 expression. World J Gastroenterol 24(4):494\u2013503","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11263_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3748\/wjg.v22.i1.275","volume":"22","author":"Y Haruyama","year":"2016","unstructured":"Haruyama Y, Kataoka H (2016) Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma. World J Gastroenterol 22(1):275\u2013283","journal-title":"World J Gastroenterol"},{"key":"11263_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920910347","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu X et al (2020) Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release. Ther Adv Med Oncol 12:1758835920910347","journal-title":"Ther Adv Med Oncol"},{"issue":"7","key":"11263_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4252\/wjsc.v13.i7.795","volume":"13","author":"CHC Sukowati","year":"2021","unstructured":"Sukowati CHC, El-Khobar KE, Tiribelli C (2021) Immunotherapy against programmed death-1\/programmed death ligand 1 in hepatocellular carcinoma: importance of molecular variations, cellular heterogeneity, and cancer stem cells. World J Stem Cells 13(7):795\u2013824","journal-title":"World J Stem Cells"},{"issue":"10","key":"11263_CR9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4254\/wjh.v16.i10.1158","volume":"16","author":"WH Cao","year":"2024","unstructured":"Cao WH et al (2024) Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients. World J Hepatol 16(10):1158\u20131168","journal-title":"World J Hepatol"},{"issue":"8","key":"11263_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070345","volume":"8","author":"YS Xiao","year":"2013","unstructured":"Xiao YS et al (2013) Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection. PLoS One 8(8):e70345","journal-title":"PLoS One"},{"issue":"3","key":"11263_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12016-024-08998-0","volume":"66","author":"MM Taheri","year":"2024","unstructured":"Taheri MM et al (2024) CAR-NKT cells in asthma: use of NKT as a promising cell for CAR therapy. Clin Rev Allergy Immunol 66(3):328\u2013362","journal-title":"Clin Rev Allergy Immunol"},{"key":"11263_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101342","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) iNKT: a new avenue for CAR-based cancer immunotherapy. Transl Oncol 17:101342","journal-title":"Transl Oncol"},{"issue":"18","key":"11263_CR13","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1182\/blood-2013-11-541235","volume":"124","author":"A Heczey","year":"2014","unstructured":"Heczey A et al (2014) Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood 124(18):2824\u20132833","journal-title":"Blood"},{"key":"11263_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101663","volume":"32","author":"G Zhang","year":"2023","unstructured":"Zhang G et al (2023) GD2 CAR-T cells in combination with nivolumab exhibit enhanced antitumor efficacy. Transl Oncol 32:101663","journal-title":"Transl Oncol"},{"issue":"2","key":"11263_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200817","volume":"32","author":"L Zhou","year":"2024","unstructured":"Zhou L et al (2024) Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma. Mol Ther Oncolytics 32(2):200817","journal-title":"Mol Ther Oncolytics"},{"issue":"76","key":"11263_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj8760","volume":"7","author":"G Cui","year":"2022","unstructured":"Cui G et al (2022) A circulating subset of iNKT cells mediates antitumor and antiviral immunity. Sci Immunol 7(76):eabj8760","journal-title":"Sci Immunol"},{"issue":"9","key":"11263_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-018-0034-2","volume":"18","author":"CM Crosby","year":"2018","unstructured":"Crosby CM, Kronenberg M (2018) Tissue-specific functions of invariant natural killer T cells. Nat Rev Immunol 18(9):559\u2013574","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"11263_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087717","volume":"9","author":"LT Mars","year":"2014","unstructured":"Mars LT et al (2014) Invariant NKT cells regulate the CD8 T cell response during theiler\u2019s virus infection. PLoS One 9(1):e87717","journal-title":"PLoS One"},{"issue":"11","key":"11263_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s43018-020-00111-6","volume":"1","author":"R Lameris","year":"2020","unstructured":"Lameris R et al (2020) A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response. Nat Cancer 1(11):1054\u20131065","journal-title":"Nat Cancer"},{"key":"11263_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031096","author":"R Poels","year":"2021","unstructured":"Poels R et al (2021) Preclinical evaluation of invariant natural killer T cells modified with CD38 or BCMA chimeric antigen receptors for multiple myeloma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22031096","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11263_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44310-y","volume":"15","author":"E Landoni","year":"2024","unstructured":"Landoni E et al (2024) IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity. Nat Commun 15(1):89","journal-title":"Nat Commun"},{"issue":"1","key":"11263_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108597","volume":"27","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) IL-21-armored B7H3 CAR-iNKT cells exert potent antitumor effects. iScience 27(1):108597","journal-title":"iScience"},{"issue":"6","key":"11263_CR23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41591-023-02363-y","volume":"29","author":"A Heczey","year":"2023","unstructured":"Heczey A et al (2023) Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med 29(6):1379\u20131388","journal-title":"Nat Med"},{"issue":"1","key":"11263_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00275-5","volume":"43","author":"T Aoki","year":"2023","unstructured":"Aoki T, Motohashi S, Koseki H (2023) Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy. Inflamm Regen 43(1):27","journal-title":"Inflamm Regen"},{"issue":"Suppl 2","key":"11263_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00292-020-00829-1","volume":"41","author":"D Schneidawind","year":"2020","unstructured":"Schneidawind D (2020) [Invariant natural killer T cells: cellular immune regulators with cytotoxic potential]. Pathologe 41(Suppl 2):134\u2013137","journal-title":"Pathologe"},{"issue":"3","key":"11263_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1158\/0008-5472.CAN-3254-2","volume":"64","author":"HJ Wajchman","year":"2004","unstructured":"Wajchman HJ et al (2004) Ex vivo expansion of CD8\u2009+\u2009CD56\u2009+\u2009and CD8\u2009+\u2009CD56- natural killer T cells specific for MUC1 mucin. Cancer Res 64(3):1171\u20131180","journal-title":"Cancer Res"},{"issue":"4","key":"11263_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ccell.2018.08.017","volume":"34","author":"A Rotolo","year":"2018","unstructured":"Rotolo A et al (2018) Enhanced anti-lymphoma activity of CAR19-iNKT cells underpinned by dual CD19 and CD1d targeting. Cancer Cell 34(4):596-610e11","journal-title":"Cancer Cell"}],"updated-by":[{"DOI":"10.1007\/s11033-025-11263-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000}},{"DOI":"10.1007\/s11033-026-11492-9","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11263-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:10:32Z","timestamp":1770783032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11263-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11263"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11263-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"corrected publication 2025","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-026-11492-9","URL":"https:\/\/doi.org\/10.1007\/s11033-026-11492-9","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"103"}}